Circadian disruption and cancer- and treatment-related symptoms

Cancer patients experience a number of co-occurring side- and late-effects due to cancer and its treatment including fatigue, sleep difficulties, depressive symptoms, and cognitive impairment. These symptoms can impair quality of life and may persist long after treatment completion. Furthermore, the...

Full description

Bibliographic Details
Main Authors: Ali Amidi, Lisa M. Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1009064/full
_version_ 1811197280060964864
author Ali Amidi
Ali Amidi
Lisa M. Wu
Lisa M. Wu
Lisa M. Wu
Lisa M. Wu
author_facet Ali Amidi
Ali Amidi
Lisa M. Wu
Lisa M. Wu
Lisa M. Wu
Lisa M. Wu
author_sort Ali Amidi
collection DOAJ
description Cancer patients experience a number of co-occurring side- and late-effects due to cancer and its treatment including fatigue, sleep difficulties, depressive symptoms, and cognitive impairment. These symptoms can impair quality of life and may persist long after treatment completion. Furthermore, they may exacerbate each other’s intensity and development over time. The co-occurrence and interdependent nature of these symptoms suggests a possible shared underlying mechanism. Thus far, hypothesized mechanisms that have been purported to underlie these symptoms include disruptions to the immune and endocrine systems. Recently circadian rhythm disruption has emerged as a related pathophysiological mechanism underlying cancer- and cancer-treatment related symptoms. Circadian rhythms are endogenous biobehavioral cycles lasting approximately 24 hours in humans and generated by the circadian master clock – the hypothalamic suprachiasmatic nucleus. The suprachiasmatic nucleus orchestrates rhythmicity in a wide range of bodily functions including hormone levels, body temperature, immune response, and rest-activity behaviors. In this review, we describe four common approaches to the measurement of circadian rhythms, highlight key research findings on the presence of circadian disruption in cancer patients, and provide a review of the literature on associations between circadian rhythm disruption and cancer- and treatment-related symptoms. Implications for future research and interventions will be discussed.
first_indexed 2024-04-12T01:11:27Z
format Article
id doaj.art-c5ad522b2388424babd511e57844d2c4
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-12T01:11:27Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-c5ad522b2388424babd511e57844d2c42022-12-22T03:54:05ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-10-011210.3389/fonc.2022.10090641009064Circadian disruption and cancer- and treatment-related symptomsAli Amidi0Ali Amidi1Lisa M. Wu2Lisa M. Wu3Lisa M. Wu4Lisa M. Wu5Unit for Psycho-Oncology and Health Psychology, Department of Psychology and Behavioural Sciences, Aarhus University, Aarhus, DenmarkSleep and Circadian Psychology Research Group, Department of Psychology and Behavioural Sciences, Aarhus University, Aarhus, DenmarkUnit for Psycho-Oncology and Health Psychology, Department of Psychology and Behavioural Sciences, Aarhus University, Aarhus, DenmarkSleep and Circadian Psychology Research Group, Department of Psychology and Behavioural Sciences, Aarhus University, Aarhus, DenmarkAarhus Institute of Advanced Studies, Aarhus University, Aarhus, DenmarkDepartment of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, United StatesCancer patients experience a number of co-occurring side- and late-effects due to cancer and its treatment including fatigue, sleep difficulties, depressive symptoms, and cognitive impairment. These symptoms can impair quality of life and may persist long after treatment completion. Furthermore, they may exacerbate each other’s intensity and development over time. The co-occurrence and interdependent nature of these symptoms suggests a possible shared underlying mechanism. Thus far, hypothesized mechanisms that have been purported to underlie these symptoms include disruptions to the immune and endocrine systems. Recently circadian rhythm disruption has emerged as a related pathophysiological mechanism underlying cancer- and cancer-treatment related symptoms. Circadian rhythms are endogenous biobehavioral cycles lasting approximately 24 hours in humans and generated by the circadian master clock – the hypothalamic suprachiasmatic nucleus. The suprachiasmatic nucleus orchestrates rhythmicity in a wide range of bodily functions including hormone levels, body temperature, immune response, and rest-activity behaviors. In this review, we describe four common approaches to the measurement of circadian rhythms, highlight key research findings on the presence of circadian disruption in cancer patients, and provide a review of the literature on associations between circadian rhythm disruption and cancer- and treatment-related symptoms. Implications for future research and interventions will be discussed.https://www.frontiersin.org/articles/10.3389/fonc.2022.1009064/fullcircadian rhythmscancersleepfatiguecognitive impairmentdepressed mood
spellingShingle Ali Amidi
Ali Amidi
Lisa M. Wu
Lisa M. Wu
Lisa M. Wu
Lisa M. Wu
Circadian disruption and cancer- and treatment-related symptoms
Frontiers in Oncology
circadian rhythms
cancer
sleep
fatigue
cognitive impairment
depressed mood
title Circadian disruption and cancer- and treatment-related symptoms
title_full Circadian disruption and cancer- and treatment-related symptoms
title_fullStr Circadian disruption and cancer- and treatment-related symptoms
title_full_unstemmed Circadian disruption and cancer- and treatment-related symptoms
title_short Circadian disruption and cancer- and treatment-related symptoms
title_sort circadian disruption and cancer and treatment related symptoms
topic circadian rhythms
cancer
sleep
fatigue
cognitive impairment
depressed mood
url https://www.frontiersin.org/articles/10.3389/fonc.2022.1009064/full
work_keys_str_mv AT aliamidi circadiandisruptionandcancerandtreatmentrelatedsymptoms
AT aliamidi circadiandisruptionandcancerandtreatmentrelatedsymptoms
AT lisamwu circadiandisruptionandcancerandtreatmentrelatedsymptoms
AT lisamwu circadiandisruptionandcancerandtreatmentrelatedsymptoms
AT lisamwu circadiandisruptionandcancerandtreatmentrelatedsymptoms
AT lisamwu circadiandisruptionandcancerandtreatmentrelatedsymptoms